Impact of immunosuppression on development and outcome of systemic sclerosis-associated pulmonary arterial hypertension.

Saved in:
Bibliographic Details
Title: Impact of immunosuppression on development and outcome of systemic sclerosis-associated pulmonary arterial hypertension.
Authors: Rodolfi S; Centre for Rheumatology, University College London and Royal Free London NHS Foundation Trust, London, UK, and Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy., Ng CCM; Centre for Rheumatology, University College London and Royal Free London NHS Foundation Trust, London, UK, and Department of Medicine, Queen Elizabeth Hospital, Hong Kong SAR, China., Ruiz Bejerano AM; Centre for Rheumatology, University College London and Royal Free London NHS Foundation Trust, London, UK, and Rheumatology Department, Hospital Universitario Ramòn y Cajal, Madrid, Spain., Kanitkar M; Centre for Rheumatology, University College London and Royal Free London NHS Foundation Trust, London, UK., Ong VH; Centre for Rheumatology, University College London and Royal Free London NHS Foundation Trust, London, UK., Denton CP; Centre for Rheumatology, University College London and Royal Free London NHS Foundation Trust, London, UK. c.denton@ucl.ac.uk.
Source: Clinical and experimental rheumatology [Clin Exp Rheumatol] 2025 Aug; Vol. 43 (8), pp. 1492-1498. Date of Electronic Publication: 2025 Aug 01.
Publication Type: Journal Article
Journal Info: Publisher: Clinical And Experimental Rheumatology S.A.S Country of Publication: Italy NLM ID: 8308521 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0392-856X (Print) Linking ISSN: 0392856X NLM ISO Abbreviation: Clin Exp Rheumatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0392-856X
DOI:10.55563/clinexprheumatol/x0keg5